How Wellend Health Will Revolutionize Telemedicine in 2015

By Admin
On the south end of Australia sits a company that is driving efforts to end breast cancer and promote overall wellness – all via telemedicine. In...

On the south end of Australia sits a company that is driving efforts to end breast cancer and promote overall wellness – all via telemedicine.

In its newly established e-newsletter titled HOPE, Wellend Health will showcase groundbreaking facts, stories and information on women’s health.

Healthcare Global has reported on how telemedicine is driving change to the industry with major players such as Google entering the field, and Wellend Health is certain to spark change in Australia, as well.

Wellend Health was created to be a “place of wellness, not a place of illness” and the company is focused on “Helping you achieve a foundation of good health; firstly by getting your hormones in balance, and then by helping you incorporate simple and natural solutions into your daily life so that you feel well and stay well.”

These e-newsletters are sure to be a driving force in helping patients incorporate healthy changes into their daily lives. In fact, the company has already begun to make a dent in breast cancer education.

Led by Dr. Stephen Birrell – a highly regarded doctor and scientist who is also co-founder and medical director of the company – Wellend Health has created T+Ai therapy.

The treatment is directed at reducing breast density, which Dr. Birrell discovered to be linked to breast cancer. In T+Ai therapy, a personalized hormone supplement is implanted into the “fat” of the lower abdomen or lower hip that will slowly dissolve over four months.

By making individuals aware of related causes to life-threatening diseases, something as small as an e-newsletter can make all the difference to someone’s life.

To sign up for Wellend Health’s e-newsletter, click here

Share

Featured Articles

McKinsey: Women More Likely to die of Heart Attack Than Men

McKinsey Health Institute's Lucy Pérez says cardiovascular disease top killer of women yet physicians don't know their heart attack symptoms are different

Novo Nordisk Buys $1bn Cardior in CardioVascular Move

As Novo Nordisk expands into heart medicines, we profile the Danish pharma giant who in 1923 was the first to make insulin commercially available

Shoddy Chinese Syringes Sees BD Ramp-up Production

Becton Dickinson – a major supplier of syringes – said it has upped manufacturing in its US facilities after FDA warning on China-made products

AI Tool 'Picks up Early-stage Breast Cancers Doctors Missed'

Technology & AI

AstraZeneca Buys $2bn Fusion in Next-gen Cancer Drugs Move

Medical Devices & Pharma

Eli Lilly and Amazon Pharmacy Partner on Drugs Delivery

Digital Healthcare